DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Amino Chemicals Ltd
03 1Aurobindo Pharma Limited
04 1Chromo Laboratories India Private Limited
05 1Jubilant Pharmova Limited
06 1LUPIN LIMITED
07 1Pfizer Asia Manufacturing Pte Ltd
08 1Zydus Lifesciences Limited
01 1Ziprasidone
02 4Ziprasidone Hydrochloride
03 1Ziprasidone Hydrochloride Monohydrate
04 2ziprasidone hydrochloride
01 6India
02 1Malta
03 1U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ZIPRASIDONE HYDROCHLORIDE ANHYDROUS
NDC Package Code : 55111-801
Start Marketing Date : 2004-12-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66005-0027
Start Marketing Date : 2009-04-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-398
Start Marketing Date : 2024-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-010
Start Marketing Date : 2020-04-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1160
Start Marketing Date : 2011-05-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57297-330
Start Marketing Date : 2017-03-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68724-5235
Start Marketing Date : 2001-02-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65841-157
Start Marketing Date : 2018-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ziprasidone Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ziprasidone Hydrochloride, including repackagers and relabelers. The FDA regulates Ziprasidone Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ziprasidone Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ziprasidone Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ziprasidone Hydrochloride supplier is an individual or a company that provides Ziprasidone Hydrochloride active pharmaceutical ingredient (API) or Ziprasidone Hydrochloride finished formulations upon request. The Ziprasidone Hydrochloride suppliers may include Ziprasidone Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ziprasidone Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ziprasidone Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ziprasidone Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ziprasidone Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ziprasidone Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ziprasidone Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ziprasidone Hydrochloride suppliers with NDC on PharmaCompass.
We have 8 companies offering Ziprasidone Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
